Choosing between TelosRX and Voy for GLP-1 weight loss depends on where you live, what medications you need, and how much you want to pay. TelosRX serves US patients with transparent pricing from $49/mo; Voy is a UK-based clinical program with brand-name GLP-1s and a money-back guarantee.
If you're in the US and want transparent pricing, compounded GLP-1s, and needle-free options from a LegitScript-certified pharmacy, TelosRX is designed for you. If you're in the UK and prefer brand-name medications like Mounjaro or Wegovy with a clinical companion app and a money-back guarantee, Voy is worth exploring.
Start your intake →Quick comparison: TelosRX vs Voy
Compounded medications are not FDA-approved. Any prescription is subject to medical approval by a licensed provider, and approval is not guaranteed.
What is TelosRX?
TelosRX is a US-based, online-first, LegitScript-certified telehealth pharmacy focused on GLP-1 weight management. It offers compounded tirzepatide and semaglutide — including needle-free oral tirzepatide and a microdosed tirzepatide option.
The service is asynchronous: you complete a short online intake, a US-licensed provider reviews it, often within hours, and approved medication ships with free 48-hour delivery. No appointment is required. Your care team is available for messaging, dose adjustments, and quarterly labs throughout your program.
Pricing is published upfront, HSA and FSA are accepted, and you can cancel anytime.
What is Voy?
Voy is a UK-based clinical weight-loss service regulated by the MHRA and CQC — the UK equivalents of the FDA and state medical boards. Founded with input from researchers at Imperial College London, Oxford, and the University of Bath, Voy focuses on evidence-based care for patients in the United Kingdom.
Voy prescribes brand-name medications including Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda, and Wegovy Pill — all approved by UK regulators. Patients access a companion app, 24/7 AI-powered support via "Joy," at-home and in-clinic blood tests, and prescriber access. Voy also offers a money-back guarantee if patients don't lose at least 10% of body weight in six months.
Voy does not serve patients in the United States.
Medications: what each program offers
Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GLP-1 and GIP agonist. Both are studied for long-term weight management. The NIH NIDDK provides a thorough overview of prescription medications for obesity, and the FDA approved tirzepatide for chronic weight management under the brand name Zepbound.
TelosRX offers compounded tirzepatide and semaglutide — these are not FDA-approved but are prepared under federal compounding regulations. Unique to TelosRX are needle-free formats: oral tirzepatide dissolved under the tongue, and a microdosed tirzepatide plan designed for gradual titration. You can also browse the full tirzepatide program or semaglutide program.
Voy prescribes brand-name medications — Mounjaro, Wegovy, Saxenda — which are approved by UK regulators (MHRA). These are regulated brand products, not compounded. US patients cannot access Voy's prescriptions.
Key takeaway: TelosRX is available to US patients with transparent pricing from $49/mo and needle-free options. Voy serves UK patients with brand-name GLP-1s and a strong clinical accountability program. They serve different markets.
Pricing and transparency
Pricing is one area where TelosRX stands out clearly. Every TelosRX plan is listed publicly before you sign up:
- From $49 a month — microdosed tirzepatide, 12-month plan
- $99 your first month — standard tirzepatide, 12-month plan
- $145, $199, or $399 first month — 6-month, 3-month, or single-month plans
HSA and FSA payments are accepted. There are no hidden membership fees, and you can cancel anytime.
Voy does not publish pricing publicly. Prospective patients must create an account and complete an assessment to see costs. Pricing varies based on medication selected and subscription commitment, with longer plans saving up to £20 per month. Voy is priced in British pounds and is only available to UK residents.
Start your TelosRX intake to see your plan price in minutes — no account required to browse.
How the process works
TelosRX: Complete a short online intake — no appointment, no waiting room. A US-licensed provider reviews your history and goals, typically within a few hours. If approved, medication is compounded at a licensed US compounding pharmacy and shipped with free 48-hour delivery. Approval is subject to medical review and is not guaranteed.
Voy: UK patients begin with an online assessment quiz. Voy's app allows patients to speak with a prescriber quickly, and medications are dispatched with free next-day delivery in the UK. Voy's companion app tracks progress, and the clinical team includes support from academics affiliated with Imperial College London and Oxford.
Both services require a prescriber to review your case before any medication is dispensed.
Coaching and ongoing support
TelosRX provides care-team messaging throughout your plan, with dose adjustments as needed and quarterly labs included. The goal is responsive clinical touchpoints — not a one-and-done prescription.
Voy's support is a genuine strength of its program. Patients get 24/7 access to an AI-powered assistant called Joy, direct clinician access via the app, at-home blood testing, and lifestyle guidance from a companion app informed by university research partnerships. Voy also includes a money-back guarantee if patients don't achieve at least 10% body weight loss in six months.
Both programs take ongoing care seriously. Voy's app ecosystem is particularly strong for UK patients who want a structured, accountability-driven experience.
Safety and medical oversight
Both programs require prescriber review before any medication is dispensed. No one is automatically approved.
GLP-1 medications are not appropriate for everyone. Providers screen for contraindications including personal or family history of medullary thyroid carcinoma, pancreatitis, and pregnancy. Common side effects include nausea and GI changes, especially during early dose titration.
TelosRX includes quarterly labs and care-team messaging to flag concerns early. Every prescription requires medical evaluation, and approval is subject to review by a licensed provider.
Voy is regulated by the MHRA and CQC, and at-home and in-clinic blood tests are available to monitor patient health throughout treatment.
Which service is right for you?
Best for US patients who want transparent pricing, compounded GLP-1s from a LegitScript-certified pharmacy, needle-free options, and ongoing care-team support — starting from $49/mo.
Best for UK patients who want brand-name GLP-1s (Mounjaro, Wegovy), a clinical companion app with 24/7 support, and a money-back guarantee tied to results.
If you're in the US, Voy is not an option — it operates exclusively in the United Kingdom. For US-based patients comparing GLP-1 programs, TelosRX offers the most transparent starting point, with pricing published upfront and no appointment needed to begin.
Frequently Asked Questions
Is TelosRX available in the US?
Yes. TelosRX is a US-based, LegitScript-certified telehealth pharmacy serving patients across the United States. You complete an online intake, a licensed provider reviews your case, and approved medication ships with free 48-hour delivery. Approval is subject to medical evaluation and is not guaranteed.
Does Voy serve US patients?
No. Voy operates exclusively in the United Kingdom and is regulated by the MHRA and CQC. US patients looking for a GLP-1 weight-loss program would need to use a US-based telehealth service such as TelosRX. Voy's medications, pricing, and clinical oversight are all structured for the UK healthcare system.
Are TelosRX's GLP-1 medications FDA-approved?
The compounded tirzepatide and semaglutide offered by TelosRX are not FDA-approved. They are prepared under federal compounding regulations by licensed US compounding pharmacies. Voy prescribes brand-name medications approved by the UK regulator (MHRA), such as Mounjaro and Wegovy, which are distinct from US FDA-approved products.
How much does TelosRX cost?
TelosRX publishes all pricing upfront: from $49/mo for microdosed tirzepatide on a 12-month plan, and $99 your first month for standard tirzepatide on a 12-month plan. Shorter plans are available at $145, $199, or $399 for the first month. HSA and FSA are accepted. Voy does not publish pricing publicly — costs are revealed after completing an assessment.
What makes Voy's program distinctive?
Voy's standout feature is its clinical accountability model for UK patients: brand-name GLP-1 medications (Mounjaro, Wegovy, Saxenda), a companion app with 24/7 AI and clinician access, at-home blood testing, and a money-back guarantee if patients don't lose at least 10% of body weight in six months. Voy also has academic partnerships with Imperial College London and Oxford.
Does TelosRX offer needle-free GLP-1 options?
Yes. TelosRX offers oral tirzepatide — dissolved under the tongue rather than injected — and a microdosed tirzepatide plan for gradual titration. These are compounded options not available through brand-name medications. All options are subject to approval by a licensed provider.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.